期刊文献+

δ-氨基酮戊酸光动力学疗法治疗皮肤癌前病变和皮肤原位癌的疗效评价 被引量:2

δ-Aminolaevulinic acid-photodynamic therapy in the treatment of precancerous changes and carcinoma of the skin
下载PDF
导出
摘要 目的探讨δ-氨基酮戊酸光动力疗法(ALA—PDT)治疗皮肤癌前病变和皮肤原位癌的疗效。方法局部ALA—PDT治疗32例基底细胞癌、9例Bowen病、8例日光性角化病和2例女性外阴白斑患者。结果经3-6次治疗,除BCC完全缓解率为93.75%外,其余患者的皮损均可达完全缓解,完全缓解率为100%;经过3~11个月随访,除3例BCC及1例Bowen病患者外,其余患者均未见复发,其复发率分别为9.4%和11%。结论ALA—PDT是一种疗效好、无明显痛苦、无瘢痕形成、复发率低、美容效果好的治疗皮肤癌前病变和皮肤原位癌的新疗法;特别适合于头面部及外生殖器部位的多发性、较大面积皮损。 Objective To investigate the effects of δ-aminolaevulinic acid-photodynamic therapy(ALA-PDT) on precancerous changes and carcinoma of the skin. Methods Thirty-two patients with BCC,9 patients with Bowen's disease, 8 patients with ac-tinic keratosis and 2 patients with leukoplakia were treated by ALA-PDT. Results The clearance was achieved in 30 patients with BCC,9 patients with Bowen's disease,2 patients with leukoplakia and 8 patients with actinic keratosis by topical ALA-PDT were completed remission.The recurrence rates were 9.4% and 11% for three cases BCC and one Bowen's disease,respectively. Conclusion Topical ALA-PDT is a simple,effective and new treatment with lower recurrent rates,no scar formation and excellent cosmetic results for precancerous changes and carcinoma in situ of the skin,especially for the large and multifocal lesions located on the face and external genitalia.
出处 《中国现代医生》 2012年第20期152-154,共3页 China Modern Doctor
关键词 氨基酮戊酸 光动力学疗法 基底细胞癌 BOWEN病 Aminolevulinic acid BCC Bowen's disease Keratosis
  • 相关文献

参考文献16

  • 1吕卫兵.光动力学疗法治疗胃癌[J].临床荟萃,2002,17(9):548-550. 被引量:2
  • 2桑红.光动力疗法的应用研究现状[J].临床皮肤科杂志,2002,31(5):332-334. 被引量:35
  • 3Dougherty TJ.Photosensitizers:therapy and detection of malignanttumors[J]. Photochem Photobiol, 1987,45 : 879-889.
  • 4Star WM,Van't Veen AJ,Robinson DJ,et al.Topical 5-aminolevulinic acid mediated photodynamic therapy of su-perficial basal cell carcinoma using two light fractionwith a two-hour interval :long-term follow-up[J]. ActDerm Venereol(S0001-5555),2006,86(5) :412-417.
  • 5Morton CA, Brown SB ,Collins S,et al. Guidelines for topical photody- namic therapy: report of a workshop of the british photoderrnatology group[J]. Br J Dermatol (S0007-0963) ,2002,146:552-567.
  • 6Fijan S, Honigsmann H, Ortel B. Photodynamie therapy of epithclialskin tumours using deha-aminolaevulinie acid and desferrioxamine[J]. Br J Dermato, 1995,133(2) : 282-288.
  • 7Varma S,W ilsonH,KurwaHA,et al. Bowen's disease,solarkerato-ses and superficialbasal cell carcinomas treated by photodynamic ther-apy using a large-field incoherent hght source[J]. Br J Dermato ,2001,144 (3) :567-574.
  • 8Fayter D, Corbett M, et al.A systematic review of photodynamic-therapy in the treatment of pre-cancerousskin conditions , Barrett's oesophagus and cancers of the biliary contract,Brain,head and neck,lung, oesopha- gusand skin[J].Health Technology Assessment,2010,14(37) : 1-3.
  • 9Calzavara-Pinton PG,Venturini M,Sala R,et al.Methylaminolaevuli- nate-based photodynamic therapy of Bowen'sdisease and squamous cell carcinoma[J].Br J Dermatol, 2008,159 : 137 - 144.
  • 10Christensen E, Skogvoll E ,Viset T,et al.Photodynamic therapy with5- aminolaevulinic acid,dimethylsulfoxide and curettage in basalcell car- cinoma:a 6-year clinical and histological follow-up[J]. J Eur Acad Der- matol Venereol, 2009,23:58-66.

二级参考文献24

  • 1王秀丽.5-氨基酮戊酸光动力疗法在皮肤科的应用[J].上海医学,2007,30(1):5-7. 被引量:38
  • 2Kennedy JC,Pottier RH,Pross DC.Photodynamic therapy with endogenous protoporphyrin IX:basic principles and present clinical experience.J Photochem Photobiol B,1990,6(1-2):143-148.
  • 3Fijan S,Honigsmann H,Ortel B.Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine.Br J Dermatol,1995,133(2):282-288.
  • 4Varma S,Wilson H,Kurwa HA,et al.Bowen's disease,solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source.Br J Dermatol,2001,144(3):567-574.
  • 5[1]Ceburkov O, Gollnick H. Photodynamic therapy in dermatology[J].Eur J Dermatol, 2000, 10(7): 568-576.
  • 6[2]Lange N, Jichlinski P, Zellweger M, et 1. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study[J] . Br J Cancer, 1999, 80(1-2): 185-193.
  • 7[3]Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology[J]. Arch Dermatol, 2000, 10: 568-576.
  • 8[4]Bunke A, Zerbe O, Schmid H, et al. Degradation mechanism and stability of 5-aminolevulinic acid[J] . J Pharm Sci, 2000, 89(10):1335-1341.
  • 9[5]Soler AM, Warloe T, Tausjo, J, et al. Photodynamic therapy of residual or recurrent basal cell carcinoma after radiotherapy using topical 5-aminolevulinic acid or methylester aminolevulinic acid[J] . Acta Oncol, 2000, 39(5): 605-609.
  • 10[6]Szeimies RM, Karrer S, Sauerwald A, et al. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study[J]. Dermatology, 1996, 192 (3)246-251.

共引文献85

同被引文献44

  • 1颉玉胜,范文成,宋维旭,张安方,魏翠萍,刘卉.5-氨基酮戊酸光动力疗法治疗面部鳞状细胞癌的临床观察[J].中华临床医师杂志(电子版),2012,6(16):4931-4932. 被引量:7
  • 2王宏伟,王秀丽,过明霞,虞叶风.5-氨基酮戊酸乳膏光动力疗法治疗皮肤癌前病变和皮肤原位癌[J].中华皮肤科杂志,2006,39(3):137-139. 被引量:49
  • 3王秀丽.5-氨基酮戊酸光动力疗法在皮肤科的应用[J].上海医学,2007,30(1):5-7. 被引量:38
  • 4'Iasanao, Yamamoto Hirofumi, Fujita Naoki, et al, Improve- ent of the efficacy of 5-aminolevulinic acid-mediated photody- amic treatment in human oral squamous cell carcinoma HSC-4 [J]. Acta medica Okayama, 2)13,67 (3) .. 153-164.
  • 5Isabel, Garcia Sofia, Ballesta Yolanda,et al. Antimicrobial pho- todynamic activity of hypericin against methicillin-susceptible and resistant Staphylococcus aureus biofilms [J]. Future micro- biology, 2015,10(1) :347-356.
  • 6Yueshuang, Xu Baoan, Chen, et al. Applications of photonic crystals in medicine [J]. Clinical laboratory,2015,61(2) :11-16.
  • 7Brad A, Hartl Henry, Hirschberg Laura, et al. Characterizing low fluence thresholds for in vitro photodynamic therapy [J]. Bi- omedical optics express,2015,6(3) ..770-779.
  • 8徐敏,乔亮,田润丽,等.5一氨基酮戊酸光动力疗法在皮肤病及性病的应用进展[J].医学信息,2015,16(1):354-355.
  • 9Amalna Bte Ebrahim, Attia Ghayathri, Balasundaram Wouter, et al. Phthalocyanine photosensitizers as contrast agents for in vivo photoacoustic tumor imaging [J]. Biomedical optics ex- press, 2015,6(2) :591-598.
  • 10Masahiro lshizuka , Fuminori Abe, Yuki Sano, et al. Novel develop- ment of 5 - aminolevurinic acid (ALA) in cancer diagnoses and therapy [ J]. International Immunopharmacology ,2011,11 ( 3 ) :358 - 365.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部